Skin creams containing steroids widely misused in India

Image
Press Trust of India London
Last Updated : Nov 26 2015 | 3:02 PM IST
Doctors in India are witnessing a pandemic of adverse effects induced by the widespread misuse of skin creams and lotions containing steroids, an Indian dermatologist has warned.
Corticosteroids, also known as steroids, are anti-inflammatory medicines used for a range of conditions.
However, these can lead to substantial and permanent damage, especially on thin skin, such as on the face and groin, researchers said.
Side effects include pigmentation and breakdown of the skin, small and widened blood vessels on the skin, as well as bacterial and fungal infections.
Misuse can lead to resistance of infections that can make these difficult to diagnose and treat.
"Indian doctors are witnessing a pandemic of adverse effects induced by topical corticosteroids," Shyam B Verma, a consultant dermatologist based in Gujarat wrote in a study published in The BMJ.
The study of 2,926 dermatology patients in 2013 showed that 433 (14.8 per cent) were using topical steroids and 392 (90.5 per cent) had harmful effects.
As required by law in India, strong steroids can be sold only with a registered medical practitioner's prescription. However, topical steroids are exempt and can be purchased over the counter.
Another problem that leads to the inappropriate use of topical steroids is that too few specialist dermatologists are available, Verma said.
The majority of India's some 8,500 dermatologists are based in cities, while most of India's population is dispersed in villages, he said.
"So many patients seek treatment for skin disease from primary care providers, including thousands of ayurvedic and homeopathic practitioners and unqualified charlatans," he said.
Although it is illegal, they may prescribe topical corticosteroids with little or no knowledge of dermatology, and many pharmacists sell steroid creams without a prescription, ignoring the box warnings, Verma said.
Due to costs and the inconvenience of specialist dermatological consultations, patients with prescriptions often re-purchase and share drugs with friends and relatives with similar symptoms.
"Sales of such products would be unthinkable in developed nations but even qualified medical practitioners in India are ignorant about rational prescribing," he said, calling for these "irrational combinations" to be banned.
"Most developed countries restrict sales of topical corticosteroids strictly by prescription, because they should be used judiciously, for appropriate indications and duration," Verma said.
"This problem highlights the low priority that dermatology receives in India," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2015 | 3:02 PM IST

Next Story